Microscopic Colitis and Celiac Disease: Sharing More than a Diagnostic Overlap

Altres autors/es

Institut Català de la Salut

[González-Castro AM, Expósito E] Grup de Recerca d’Immunologia Translacional, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Grup de Recerca de Neuro-Immuno-Gastroenterologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Fernández-Bañares F, Zabana Y] Gastroenterology Department, University Hospital Mútua Terrassa, Terrassa, Spain. Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd, Instituto Carlos III), Madrid, Spain. [Farago-Pérez G, Ortega-Barrionuevo J] Grup de Recerca d’Immunologia Translacional, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Guagnozzi D] Grup de Recerca d’Immunologia Translacional, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Grup de Recerca de Neuro-Immuno-Gastroenterologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd, Instituto Carlos III), Madrid, Spain. Servei d’Aparell Digestiu, Vall d’Hebron Hospital Universitari, Barcelona, Spain

Vall d'Hebron Barcelona Hospital Campus

Data de publicació

2024-09-20T07:53:31Z

2024-09-20T07:53:31Z

2024-07



Resum

Autoimmunity; Celiac disease; Microscopic colitis


Autoimmunitat; Malaltia celíaca; Colitis microscòpica


Autoinmunidad; Enfermedad celíaca; Colitis microscópica


Microscopic colitis (MC) is an emergent group of chronic inflammatory diseases of the colon, and celiac disease (CD) is a chronic gluten-induced immune-mediated enteropathy affecting the small bowel. We performed a narrative review to provide an overview regarding the relationship between both disorders, analyzing the most recent studies published at the epidemiological, clinical and pathophysiological levels. In fact, MC and CD are concomitantly prevalent in approximately 6% of the cases, mainly in the subset of refractory patients. Thus, physicians should screen refractory patients with CD against MC and vice versa. Both disorders share more than a simple epidemiological association, being multifactorial diseases involving innate and adaptive immune responses to known or unknown luminal factors based on a rather common genetic ground. Moreover, autoimmunity is a shared characteristic between the patients with MC and those with CD, with autoimmunity in the latter being quite well-established. Furthermore, CD and MC share some common clinical symptoms and risk factors and overlap with other gastrointestinal diseases, but some differences exist between both disorders. More studies are therefore needed to better understand the complex mechanisms involving the common pathogenetic ground contributing to the CD and MC epidemiological association.

Tipus de document

Article


Versió publicada

Llengua

Anglès

Publicat per

MDPI

Documents relacionats

Nutrients;16(14)

https://doi.org/10.3390/nu16142233

Citació recomanada

Aquesta citació s'ha generat automàticament.

Drets

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

Aquest element apareix en la col·lecció o col·leccions següent(s)